Ophthalmology
Dr. Adam T. Gerstenblith, MD
Adam T. Gerstenblith practices Ophthalmology. Adam T. Gerstenblith, MD is registered with Medicare and accepts Medicare payments.
Schools
Johns Hopkins University School of Medicine
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Ocular Prosthetics
- Removal of Foreign Body from External Eye
- View All
Conditions Treated
- Acute Endophthalmitis
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Aphakia and Other Disorders of Lens
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Amalgamated Clothing & Textile Workers Union WC
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Blue Choice Advantage
- Blue Choice Network POS
- Blue Preferred PPO
- CareFirst Maryland POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Southern Health PPO
- First Health (Coventry Health Care) PPO
- HealthPartners
- Community Blue PPO
- Keystone Health Plan East HMO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Freedom Plan
- Planned Administration Inc
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- UPMC PPO
Drug Facts
NPI NUMBER |
|
1265654875 |
NPPES Provider LastName |
|
GERSTENBLITH |
NPPES Provider FirstName |
|
ADAM |
NPPES Provider ZIPCode |
|
191075109 |
NPPES Provider State |
|
PA |
Specialty Description |
|
Ophthalmology |
Total Claim Count |
|
212.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1265654875 |
Last Name Of The Provider |
GERSTENBLITH |
First Name Of The Provider |
ADAM |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog